Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment

(NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker ...
Nasdaq

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

Real-world data showing NeuroStar is effective in adolescents and young adults with depression from the world’s largest TMS outcomes dataset MALVERN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics ...
Nasdaq

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

MALVERN, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of ...
Insider Monkey

Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting

Neuronetics Inc. (NASDAQ:STIM) is one of the best-performing NASDAQ stocks according to analysts. On June 10, Neuronetics announced its significant presence at the 13th Annual Clinical TMS ...
Fierce Healthcare

Evernorth expands coverage of NeuroStar depression therapy to adolescents

Cigna's Evernorth unit is expanding coverage for Neuronetics' therapy for depression to adolescents. Neuronetics announced that Evernorth will offer coverage for its NeuroStar Transcranial Magnetic ...
EurekAlert!

NeuroStar TMS therapy shows favorable outcomes compared to antidepressants for depression

NEW YORK, May 6, 2014 – Neuronetics, Inc. announced today a new analysis of data at the annual meeting of the American Psychiatric Association that shows Transcranial Magnetic Stimulation (TMS) ...
manilatimes

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

MALVERN, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life ...
Medindia

Long-Term Benefit of NeuroStar TMS Therapy in Depression

Neuronetics, Inc., announced that results of a study designed to assess the long-term effectiveness of NeuroStar TMS Therapy in adult patients with Major Depressive Disorder (MDD) who have failed to ...
Yahoo Finance

Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy

MALVERN, Pa., June 12, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life ...
Monthly Prescribing Reference

Positive Results Seen with NeuroStar TMS for Postpartum Depression

NeuroStar TMS Therapy, a non-pharmacologic treatment, demonstrated positive results for women with postpartum depression. NeuroStar TMS Therapy, a non-pharmacologic treatment, demonstrated positive ...
Monthly Prescribing Reference

TMS Device NeuroStar Cleared as Add-On Treatment for Adolescent Depression

NeuroStar Advanced Therapy is a transcranial magnetic stimulation system that uses magnetic fields to induce neural activity in the cerebral cortex. The Food and Drug Administration (FDA) has cleared ...